Germany Accounted for Maximum Market Share in European Vitreoretinal Market

“The European Vitreoretinal Market is estimated to grow at a CAGR of 13.5% from 2014-2019. Germany accounted for the maximum market share and is estimated to grow at a CAGR of 9.9%. France accounted for the second largest market share. Vitreoretinal market is divided into sub-types (Photocoagulation, Vitrectomy, and Illumination Devices), where the repair by photocoagulation segment has the highest market share and shows a comparatively higher growth rate among the other segments.

There have been many developments in the market, such as approvals received by the top players and collaborations to increase the technical efficiency of the procedures and deliver good results in the market. Abbott received U.S. Food and Drug Administration clearance for its iFS Advanced femtosecond laser used in corneal and cataract surgery. The product has helped to create bow-shaped or curved arcuate incisions during surgery. The approval strengthened AMO’s Femtosecond laser technology for ophthalmology and offered an advanced technique for cataract procedures. 

The overall market growth has been positive and is continued to remain similar until 2019. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the European vitreoretinal surgery devices market.

The key players in the European vitreoretinal surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.) and many more.
“